๐ฐ Real World Setting News
Real World Setting News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Real World Setting. Real-time updates on events, politics, business and more.
August 24, 2023
The multi-center study led to several important findings, one of which being that history of biologic-use could be a factor of importance in secukinumab retention prediction.
June 4, 2023
It should come as no surprise to readers that the general public overwhelmingly assumes that religion is tied to morality. This can be de scribed as the โReligion Makes You Good" theory. In more scientific terms, this โreligious prosociality hypothesis" predicts that religious belief i ...
May 17, 2023
Strict inclusion and exclusion criteria in clinical trials means findings on health-related quality of life (HRQOL) may not be generalizable to the real-world setting.
May 9, 2023
New data suggests that anti-IL-17A biologics including ixekizumab showed strong self-reported results in signs and symptoms for psoriasis patients.
March 14, 2023
/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the...
December 11, 2022
โ Actively Enrolling Phase 3 ENERGIZE and ENERGIZE-T Studies Evaluating PYRUKYND® in Adults with Non-transfusion-dependent and Transfusion-dependent ฮฑ- or...
October 18, 2022
- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data
January 13, 2022
In this study, researchers identified and recruited volunteers who received inactivated COVID-19 vaccines in real-world settings.
November 3, 2021
Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...